Xiao-Chai-Hu-Tang mitigates irinotecan-induced toxicity in CRC via gut microbiota
Xiao-Chai-Hu-Tang (XCHT) alleviates irinotecan-induced intestinal toxicity and enhances antitumor immunity in CRC models by restoring gut microbiota and metabolites.
Asset / Drug
Drug and asset intelligence for Xiao-Chai-Hu-Tang with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.